Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

VALEANT PHARMACEUTICALS INTL INC > Look to Q2 2016
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Fullblaston Mar 18, 2016 8:40pm
210 Views
Post# 24677904

RE:RE:RE:RE:Look to Q2 2016

RE:RE:RE:RE:Look to Q2 2016
Groupguru. you don't know me. I bought biovail for 8$ in 2007, before it became VRX. I sold VRX, last October, at 305$ when it started to tank. I made a fortune. I reinvested a small part of this fortune in VRX at 47$ earlier this week. Welcome to my ignore list.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities